Amanote Research
Register
Sign In
Expression of KLF5 Is a Prognostic Factor for Disease-Free Survival and Overall Survival in Patients With Breast Cancer
Clinical Cancer Research
- United States
doi 10.1158/1078-0432.ccr-05-0964
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Oncology
Date
April 15, 2006
Authors
D. Tong
Publisher
American Association for Cancer Research (AACR)
Related search
Figure 5: Overall Survival and Disease-Free Survival Analyses of Different HELLS Expression Lung Cancer Patients.
Figure 6: Overall Survival and Disease-Free Survival Analyses of Different ICAM1 Expression Lung Cancer Patients.
Disease-Free Survival in Patients With Non-Metastatic Breast Cancer
Revista da Associacao Medica Brasileira
Medicine
High HSF4 Expression Is an Independent Indicator of Poor Overall Survival and Recurrence Free Survival in Patients With Primary Colorectal Cancer
IUBMB Life
Biochemistry
Genetics
Clinical Biochemistry
Cell Biology
Molecular Biology
Overall Survival and Progression-Free Survival in Patients With Primary Brain Tumors After Treatment: Is the Outcome of [18F] FDOPA PET a Prognostic Factor in These Patients?
Annals of Nuclear Medicine
Medicine
Nuclear Medicine
Radiology
Imaging
Prognostic Nomograms to Predict Overall Survival and Cancer-Specific Survival in Patients With Pelvic Chondrosarcoma
Cancer Medicine
Cancer Research
Nuclear Medicine
Radiology
Imaging
Oncology
Age Is a Prognostic Factor Affecting Survival in Lung Cancer Patients
Oncology Letters
Cancer Research
Oncology
Metastasis-Free Survival Is a Strong Surrogate of Overall Survival in Localized Prostate Cancer
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Prognostic Nomograms and Aggtrmmns Scoring System for Predicting Overall Survival and Cancer‐specific Survival of Patients With Kidney Cancer
Cancer Medicine
Cancer Research
Nuclear Medicine
Radiology
Imaging
Oncology
